Schedule of Material Differences in Employment Agreements between Navidea Biopharmaceuticals, Inc. and Named Executives

Summary

This document lists key differences in employment agreements between Navidea Biopharmaceuticals, Inc. and five executives. It details each executive’s employment start and end dates, 2012 base salary, and the amounts they would receive as severance, both under normal circumstances and in the event of a change in control. The schedule provides a clear comparison of compensation and severance terms for Mark J. Pykett, Thomas H. Tulip, Frederick O. Cope, Brent L. Larson, and Rodger A. Brown.

EX-10.5 3 v303459_ex10-5.htm EXHIBIT 10.5

Exhibit 10.5

 

SCHEDULE IDENTIFYING MATERIAL DIFFERENCES BETWEEN

EMPLOYMENT AGREEMENTS

BETWEEN NAVIDEA BIOPHARMACEUTICALS, INC. AND

THE INDIVIDUALS LISTED BELOW

 

  Commencement
Date
   Termination
Date
   2012 Base
Salary
   Amount of
Severance
   Amount of
Severance
upon Change in
Control
 
                          
Mark J. Pykett   4/15/2011    10/15/2012   $425,000   $468,750   $937,500 
                          
Thomas H. Tulip   6/1/2011    5/31/2012   $300,000   $225,000   $450,000 
                          
Frederick O. Cope   1/1/2011    12/31/2012   $271,000   $245,000   $367,500 
                          
Brent L. Larson   1/1/2011    12/31/2012   $265,000   $207,000   $310,500 
                          
Rodger A. Brown   1/1/2011    12/31/2012   $191,000   $165,000   $247,500